HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anna Maria Barbui Selected Research
Anna Maria Barbui Research Topics
Disease
5
Infections
06/2023 - 01/2004
4
Neoplasms (Cancer)
12/2022 - 07/2007
3
Multiple Myeloma
12/2005 - 01/2002
2
B-Cell Lymphoma (Lymphoma, B Cell)
03/2024 - 11/2016
2
Lymphoma (Lymphomas)
12/2022 - 02/2018
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 12/2013
2
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2021 - 01/2021
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2019 - 10/2018
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 06/2003
2
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 07/2007
1
Meningococcal Infections
01/2023
1
Hypertension (High Blood Pressure)
11/2022
1
Sepsis (Septicemia)
09/2022
1
COVID-19
01/2021
1
Mucormycosis
01/2019
1
Second Primary Neoplasms (Neoplasms, Second)
10/2018
1
Gonorrhea
06/2018
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2015
1
Invasive Fungal Infections
10/2014
1
Arthritis (Polyarthritis)
04/2014
1
Pulmonary Tuberculosis
04/2014
1
Disease Progression
12/2005
1
Fatigue
06/2005
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2004
Drug/Important Bio-Agent (IBA)
3
Rituximab (Mabthera)
FDA Link
11/2019 - 12/2013
2
Anti-Bacterial Agents (Antibiotics)
IBA
11/2022 - 06/2018
1
axicabtagene ciloleucel
IBA
03/2024
1
Fosfomycin
FDA Link
06/2023
1
4CMenB vaccine
IBA
01/2023
1
insulin receptor-related receptor (IRR)
IBA
01/2023
1
Vaccines
IBA
01/2023
1
Recombinant Proteins
IBA
01/2023
1
Protein Isoforms (Isoforms)
IBA
12/2022
1
Liver X Receptors
IBA
12/2022
1
Immunomodulating Agents
IBA
11/2022
1
meropenem and vaborbactam
IBA
09/2022
1
Cefiderocol
IBA
09/2022
1
tazobactam drug combination ceftolozane
IBA
09/2022
1
ceftazidime drug combination avibactam
IBA
09/2022
1
Monoclonal Antibodies
IBA
11/2021
1
tafasitamab
IBA
11/2021
1
Lenalidomide (CC 5013)
FDA Link
11/2021
1
Antigens
IBA
01/2021
1
liposomal amphotericin B
FDA Link
01/2019
1
isavuconazole
IBA
01/2019
1
obinutuzumab
IBA
10/2018
1
Bendamustine Hydrochloride
FDA Link
10/2018
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2018
1
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2018
1
Gallium
IBA
10/2018
1
Prednisone (Sone)
FDA Link
Generic
10/2018
1
Vincristine (Oncovin)
FDA Link
Generic
10/2018
1
Tenascin
IBA
02/2018
1
Glycoproteins (Glycoprotein)
IBA
02/2018
1
Azoles
IBA
10/2014
1
posaconazole
FDA Link
10/2014
1
Moxifloxacin (Avelox)
FDA Link
04/2014
1
Cytokines
IBA
07/2007
1
Hemoglobins (Hemoglobin)
IBA
06/2005
1
Hepatitis C Antibodies
IBA
01/2004
1
RNA (Ribonucleic Acid)
IBA
01/2004
1
Antineoplastic Agents (Antineoplastics)
IBA
06/2003
1
Gemtuzumab (Mylotarg)
FDA Link
06/2003
1
Caspase 3 (Caspase-3)
IBA
06/2003
1
Calicheamicins
IBA
06/2003
Therapy/Procedure
6
Drug Therapy (Chemotherapy)
11/2019 - 12/2005
3
Stem Cell Transplantation
01/2021 - 01/2015
3
Therapeutics
11/2019 - 01/2015
2
Immunotherapy
10/2021 - 11/2019
2
Autologous Transplantation
12/2005 - 01/2002
1
Hematopoietic Stem Cell Transplantation
01/2019
1
Radioimmunotherapy
02/2018
1
Radiotherapy
07/2007
1
Salvage Therapy
07/2007
1
Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2004